Literature DB >> 32245834

Development of an RNA Strand-Specific Hybridization Assay To Differentiate Replicating versus Nonreplicating Influenza A Viruses.

Genyan Yang1, Erin N Hodges2, Jörn Winter2, Natosha Zanders2, Svetlana Shcherbik2, Tatiana Bousse2, Janna R Murray2, A K M Muraduzzaman3, Mahbubur Rahman3, A S M Alamgir3, Meerjady Sabrina Flora3, Lenee Blanton2, John R Barnes2, David E Wentworth2, C Todd Davis2.   

Abstract

Replication of influenza A virus (IAV) from negative-sense viral RNA (vRNA) requires the generation of positive-sense RNA (+RNA). Most molecular assays, such as conventional real-time reverse transcriptase PCR (rRT-PCR), detect total RNA in a sample without differentiating vRNA from +RNA. These assays are not designed to distinguish IAV infection versus exposure of an individual to an environment enriched with IAVs but wherein no viral replication occurs. We therefore developed a strand-specific hybridization (SSH) assay that differentiates between vRNA and +RNA and quantifies relative levels of each RNA species. The SSH assay exhibited a linearity of 7 logs with a lower limit of detection of 6.0 × 102 copies of molecules per reaction. No signal was detected in samples with a high load of nontarget template or influenza B virus, demonstrating assay specificity. IAV +RNA was detected 2 to 4 h postinoculation of MDCK cells, whereas synthesis of cold-adapted IAV +RNA was significantly impaired at 37°C. The SSH assay was then used to test IAV rRT-PCR positive nasopharyngeal specimens collected from individuals exposed to IAV at swine exhibitions (n = 7) or while working at live bird markets (n = 2). The SSH assay was able to differentiate vRNA and +RNA in samples collected from infected, symptomatic individuals versus individuals who were exposed to IAV in the environment but had no active viral replication. Data generated with this technique, especially when coupled with clinical data and assessment of seroconversion, will facilitate differentiation of actual IAV infection with replicating virus versus individuals exposed to high levels of environmental contamination but without virus infection.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  RNA species; influenza A virus (IAV) infection; replication; single-strand hybridization (SSH) assay

Mesh:

Substances:

Year:  2020        PMID: 32245834      PMCID: PMC7269401          DOI: 10.1128/JCM.00252-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics.

Authors:  Diana Vester; Antje Lagoda; Diana Hoffmann; Claudius Seitz; Stefan Heldt; Katja Bettenbrock; Yvonne Genzel; Udo Reichl
Journal:  J Virol Methods       Date:  2010-04-28       Impact factor: 2.014

2.  Adaptive strategies of the influenza virus polymerase for replication in humans.

Authors:  Andrew Mehle; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

3.  Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.

Authors:  Y H Leung; W L Lim; M H Wong; S K Chuang
Journal:  Epidemiol Infect       Date:  2011-07-29       Impact factor: 2.451

4.  Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.

Authors:  Andrew J Broadbent; Celia P Santos; Amanda Anafu; Eckard Wimmer; Steffen Mueller; Kanta Subbarao
Journal:  Vaccine       Date:  2015-12-02       Impact factor: 3.641

5.  The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.

Authors:  Winnie Chan; Helen Zhou; George Kemble; Hong Jin
Journal:  Virology       Date:  2008-09-02       Impact factor: 3.616

Review 6.  An updated systematic review of the role of host genetics in susceptibility to influenza.

Authors:  Peter Horby; Nhu Y Nguyen; Sarah J Dunstan; John Kenneth Baillie
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

7.  Highly pathogenic Avian Influenza A(H5N1) virus infection among workers at live bird markets, Bangladesh, 2009-2010.

Authors:  Sharifa Nasreen; Salah Uddin Khan; Stephen P Luby; Emily S Gurley; Jaynal Abedin; Rashid Uz Zaman; Badrul Munir Sohel; Mustafizur Rahman; Kathy Hancock; Min Z Levine; Vic Veguilla; David Wang; Crystal Holiday; Eric Gillis; Katharine Sturm-Ramirez; Joseph S Bresee; Mahmudur Rahman; Timothy M Uyeki; Jacqueline M Katz; Eduardo Azziz-Baumgartner
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

8.  Asymptomatic, mild, and severe influenza A(H7N9) virus infection in humans, Guangzhou, China.

Authors:  Zongqiu Chen; Hui Liu; Jianyun Lu; Lei Luo; Kuibiao Li; Yufei Liu; Eric H Y Lau; Biao Di; Hui Wang; Zhicong Yang; Xincai Xiao
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

9.  CNOT4-Mediated Ubiquitination of Influenza A Virus Nucleoprotein Promotes Viral RNA Replication.

Authors:  Yu-Chen Lin; King-Song Jeng; Michael M C Lai
Journal:  MBio       Date:  2017-05-23       Impact factor: 7.867

Review 10.  Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.

Authors:  Dan Dou; Rebecca Revol; Henrik Östbye; Hao Wang; Robert Daniels
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

View more
  1 in total

1.  Natural immunity to influenza A and B among Saudi blood donors in Al Madinah Al Munawarah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim; Khalid S Alahmadi; Abdullah K Al-Harbi; Mohammed A Almughthawi; Omar A Alhazmi; Fayez H Alsehli; Omar F Khabour
Journal:  Saudi Med J       Date:  2020-12       Impact factor: 1.484

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.